Dr. Reddy's Laboratories (DRREDDY) — Board Meeting

Dr. Reddy's Laboratories reported a 16% YoY revenue increase to ₹83.59 crores in Q3FY25, driven by strong performance in Europe and new product launches, with net profit rising 2% YoY to ₹14,133 million. The company completed acquisitions of Haleon's NRT business and Nestle India's nutraceutical portfolio, while facing ongoing U.S. anti-corruption scrutiny. Strategic moves including a stock split and nutraceutical subsidiary formation support long-term growth amid integration costs.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DRREDDY ✨ Ask AI About This

About Dr. Reddy's Laboratories Limited (DRREDDY)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,11,568.6 Cr P/E: 20.0 ROE: 16.6% ROCE: 19.7%

View full DRREDDY stock details →

📡 Get AI alerts when DRREDDY files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DRREDDY — Free

💡 Ask AI about this filing

"How does this board meeting affect Dr. Reddy's Laboratories Limited's outlook?" "What did Dr. Reddy's Laboratories Limited announce on 23 January 2025?" "Is this positive or negative for DRREDDY?"

Ask AI Free →

📊 More DRREDDY filings

See all DRREDDY filings →

🔥 Also filed on 23 January 2025

SIEMENS Siemens Limited Corporate Action SRF SRF Limited Corporate Action TATACONSUM TATA CONSUMER PRODUCTS LIMITED Financial Results TECHM Tech Mahindra Limited Announcement ULTRACEMCO UltraTech Cement Limited Financial Results ULTRACEMCO UltraTech Cement Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DRREDDY files new disclosures

Track DRREDDY filings, board meetings, and corporate actions. Free email alerts at 5 PM.